Glutaminases in brain: Multiple isoforms for many purposes. (September 2015)

• Record Type: Journal Article
• Authors: Campos-Sandoval, José A.; Martín-Rufián, Mercedes; Cardona, Carolina; Lobo, Carolina; Peñalver, Ana; Márquez, Javier
• Is Part Of: Neurochemistry international. Volume 88(2015)
• Page Start: 1
• Page End: 5
• Publication Date: 2015-09
• Subjects: Glutaminase isoforms -- Glutamine -- Glutamate -- Brain -- Cancer -- Glioma; Neurochemistry -- Periodicals; Neurochemistry -- Periodicals; Neurochimie -- Périodiques; Neurochemistry; Periodicals; 612.804205
• DOI: 10.1016/j.neuint.2015.03.006
• Languages: English
• ISSNs: 0197-0186

Abstract

Highlights: New glutaminase isoforms and extramitochondrial localizations support their role as multifunctional proteins. Mitochondrial expression in neurons and astrocytes is relevant for the energy metabolism and Glu/Gln cycle. Nuclear expression in brain cells might be associated with transcriptional regulation. Glutaminase isoforms play opposing roles in cancer and may become new therapeutic targets. Abstract: Glutaminase is expressed in most mammalian tissues and cancer cells, but recent studies are now revealing a considerably degree of complexity in its pattern of expression and functional regulation. Novel transcript variants of the mammalian glutaminase Gls2 gene have been recently found and characterized in brain. Co-expression of different isoforms in the same cell type would allow cells to fine-tune their Gln/Glu levels under a wide range of metabolic states. Moreover, the discovery of protein interacting partners and novel subcellular localizations, for example nucleocytoplasmic in neurons and astrocytes, strongly suggest non-neurotransmission roles for Gls2 isoforms associated with transcriptional regulation and cellular differentiation. Of note, Gls isoforms have been considered as an important trophic factor for neuronal differentiation and postnatal development of brain regions. On the other hand, glutaminases are taking center stage in tumor biology as new therapeutic targets to inhibit metabolic reprogramming of cancer cells. Interestingly, glutaminase isoenzymes play seemingly opposing roles in cancer cell growth and proliferation; this issue will be also succinctly discussed with special emphasis on brain tumors.